Literature DB >> 19855856

Driving on antidepressants: cruising for a crash?

Randy A Sansone1, Lori A Sansone.   

Abstract

Antidepressants are commonly prescribed medications that carry an imprecise risk of driving impairment. In this edition of The Interface, we explore the relationship between antidepressant medications and driving impairment. We conclude that while there may be a small risk of driving impairment with these medications, this risk is considerably heightened under particular clinical conditions. These conditions include the advanced age of the driver, initial dosing and start-up of the antidepressant, rapid escalation of antidepressant doses, high-dose antidepressants, presence of active and severe depressive symptoms (i.e., the antidepressant is merely functioning as a pharmacological marker for severe depressive illness), and/or coadministration of other psychotropic medications, especially benzodiazepines. Clinicians need to be mindful of these specific clinical conditions when prescribing antidepressants to patients.

Entities:  

Keywords:  antidepressants; driving; motor vehicle; psychotropic medications

Year:  2009        PMID: 19855856      PMCID: PMC2766284     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  12 in total

Review 1.  Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.

Authors:  Johannes G Ramaekers
Journal:  J Clin Psychiatry       Date:  2003-01       Impact factor: 4.384

2.  Psychoactive substance use and the risk of motor vehicle accidents.

Authors:  K L L Movig; M P M Mathijssen; P H A Nagel; T van Egmond; J J de Gier; H G M Leufkens; A C G Egberts
Journal:  Accid Anal Prev       Date:  2004-07

3.  Trends in psychotropic medication use among U.S. adults.

Authors:  Ryne Paulose-Ram; Marc A Safran; Bruce S Jonas; Qiuping Gu; Denise Orwig
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-05       Impact factor: 2.890

4.  Utilization, price, and spending trends for antidepressants in the US Medicaid Program.

Authors:  Yan Chen; Christina M L Kelton; Yonghua Jing; Jeff J Guo; Xing Li; Nick C Patel
Journal:  Res Social Adm Pharm       Date:  2008-08-08

5.  Psychotropic drugs and road accidents.

Authors:  D Wheatley
Journal:  Br Med J       Date:  1977-07-09

6.  Minor increase in risk of road traffic accidents after prescriptions of antidepressants: a study of population registry data in Norway.

Authors:  Jørgen G Bramness; Svetlana Skurtveit; C Ineke Neutel; Jørg Mørland; Anders Engeland
Journal:  J Clin Psychiatry       Date:  2008-07       Impact factor: 4.384

7.  Association of road-traffic accidents with benzodiazepine use.

Authors:  F Barbone; A D McMahon; P G Davey; A D Morris; I C Reid; D G McDevitt; T M MacDonald
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

8.  The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.

Authors:  Alexander Brunnauer; Gerd Laux; Irmgard David; Mirijam Fric; Igor Hermisson; Hans-Jürgen Möller
Journal:  J Clin Psychiatry       Date:  2008-10-07       Impact factor: 4.384

9.  Fitness to drive of psychiatric patients.

Authors:  Carlos De Las Cuevas; Emilio J Sanz
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers.

Authors:  W A Ray; R L Fought; M D Decker
Journal:  Am J Epidemiol       Date:  1992-10-01       Impact factor: 4.897

View more
  3 in total

1.  Latent Classes of Polydrug Users as a Predictor of Crash Involvement and Alcohol Consumption.

Authors:  Michael Scherer; Eduardo Romano; Robert Voas; Eileen Taylor
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

Review 2.  Marijuana use and motor vehicle crashes.

Authors:  Mu-Chen Li; Joanne E Brady; Charles J DiMaggio; Arielle R Lusardi; Keane Y Tzong; Guohua Li
Journal:  Epidemiol Rev       Date:  2011-10-04       Impact factor: 6.222

Review 3.  Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.

Authors:  Katharine Barnard; Robert C Peveler; Richard I G Holt
Journal:  Diabetes Care       Date:  2013-10       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.